acc01751 |
PAX3- and PAX7-binding protein 1 |
phosphorylation |
Ser558 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01752 |
Nuclear receptor corepressor 2 |
phosphorylation |
Ser149 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01753 |
Serine/threonine-protein kinase 24 |
phosphorylation |
Ser315 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01754 |
Serine/threonine-protein kinase 24 |
phosphorylation |
Ser316 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01755 |
eIF5-mimic protein 1 |
phosphorylation |
Ser412 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01756 |
eIF5-mimic protein 1 |
phosphorylation |
Ser414 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01757 |
Cytoplasmic dynein 1 light intermediate chain 1 |
phosphorylation |
Ser207 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01758 |
Zinc finger CCCH domain-containing protein 11A |
phosphorylation |
Thr321 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01759 |
Pre-mRNA-processing factor 40 homolog A |
phosphorylation |
Thr932 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01760 |
Splicing factor 3B subunit 1 |
phosphorylation |
Thr326 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01761 |
Splicing factor 3B subunit 1 |
phosphorylation |
Thr328 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01762 |
Eukaryotic translation initiation factor 3 subunit G |
phosphorylation |
Thr41 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01763 |
PHD finger protein 14 |
phosphorylation |
Thr287 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01764 |
Protein HEXIM1 |
phosphorylation |
Thr236 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01765 |
Epsin-2 |
phosphorylation |
Thr508 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01766 |
Chromosome-associated kinesin KIF4A |
phosphorylation |
Thr1181 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01767 |
Retinoblastoma-associated protein |
phosphorylation |
Thr821 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01768 |
Retinoblastoma-associated protein |
phosphorylation |
Thr826 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01769 |
DNA topoisomerase 2-alpha |
phosphorylation |
Thr1343 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01770 |
Histone H1.5 |
phosphorylation |
Thr11 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01771 |
Eukaryotic translation initiation factor 2 subunit 2 |
phosphorylation |
Thr111 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01772 |
Cyclin-dependent kinase 3 |
phosphorylation |
Thr14 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01773 |
Cyclin-dependent kinase 2 |
phosphorylation |
Thr14 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01774 |
Cyclin-dependent kinase 1 |
phosphorylation |
Thr14 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01775 |
Elongation factor 1-delta |
phosphorylation |
Thr147 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01776 |
Ubiquitin carboxyl-terminal hydrolase 5 |
phosphorylation |
Thr623 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01777 |
Microtubule-associated protein 1B |
phosphorylation |
Thr1067 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01778 |
Microtubule-associated protein 1B |
phosphorylation |
Thr1270 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01779 |
Microtubule-associated protein 1B |
phosphorylation |
Thr1282 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01780 |
Microtubule-associated protein 1B |
phosphorylation |
Thr1932 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01781 |
Casein kinase I isoform delta |
phosphorylation |
Thr347 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01782 |
E3 SUMO-protein ligase RanBP2 |
phosphorylation |
Thr1393 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01783 |
Transformer-2 protein homolog beta |
phosphorylation |
Thr201 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01784 |
Neuroblast differentiation-associated protein AHNAK |
phosphorylation |
Thr4100 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01785 |
Treacle protein |
phosphorylation |
Thr84 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01786 |
Splicing factor 3B subunit 2 |
phosphorylation |
Thr311 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01787 |
Sequestosome-1 |
phosphorylation |
Thr269 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01788 |
Pericentriolar material 1 protein |
phosphorylation |
Thr530 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01789 |
Coiled-coil domain-containing protein 6 |
phosphorylation |
Thr380 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01790 |
Serine/threonine-protein kinase N2 |
phosphorylation |
Thr958 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01791 |
Inverted formin-2 |
phosphorylation |
Thr1179 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01792 |
Rab-like protein 6 |
phosphorylation |
Thr599 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01793 |
La-related protein 7 |
phosphorylation |
Thr338 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01794 |
Rho GTPase-activating protein 29 |
phosphorylation |
Thr544 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01795 |
Nucleolar MIF4G domain-containing protein 1 |
phosphorylation |
Thr287 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01796 |
Zinc finger CCCH domain-containing protein 13 |
phosphorylation |
Thr263 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01797 |
AP-1 complex-associated regulatory protein |
phosphorylation |
Thr228 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01798 |
WASH complex subunit 2A |
phosphorylation |
Thr331 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01799 |
WASH complex subunit 2C |
phosphorylation |
Thr331 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01800 |
RNA polymerase-associated protein CTR9 homolog |
phosphorylation |
Thr925 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|